Effective treatment sequencing in patients with metastatic breast cancer is critical for maximizing clinical benefit and maintaining quality of life. Ms. Ashley Baker sits down with Dr. Giancarlo Moscol to discuss how to approach sequencing decisions based on tumor biology, disease progression patterns, and actionable mutations. Dr. Moscol is an Associate Professor in the Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston.